We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Zeesan Biotech Displays DNA Automated Extraction System

By LabMedica International staff writers
Posted on 05 Feb 2018
Zeesan Biotech (Fujian, China) displayed its DNA automated extraction system and real-time PCR kits for MDR/XDR-TB, HPV, HBB, etc. More...
at MEDLAB Middle East, the world’s largest attended laboratory and IVD exhibition and conference.
 
Zeesan is a biomedical company specializing in the development and production of molecular diagnostics related kits, instruments and reagents. The company’s product range includes the MeltPro series of molecular diagnostics products, automated DNA extraction machines and visible-light gel electrophoresis systems. At the MEDLAB Middle East 2018 held in Dubai, UAE, from February 5-8, 2018, Zeesan exhibited its Lab-Aid 824 nucleic acid extraction system, which enables automated, fast, reliable isolation and purification of high-quality nucleic acids for up to 24 samples per run. The entire extraction process is controlled by software and the system is intended for in vitro diagnostic use to provide high quality nucleic acid suitable for direct use in downstream application, such as amplification or other enzymatic reactions.
 
Visitors at Zeesan’s stand at the event also viewed the company’s wide range of real-time PCR kits for MDR/XDR-TB, HPV, HBB, etc. The company’s MeltPro High Risk HPV Genotyping Assay is a qualitative in vitro test kit used for HPV genotyping using cervical cells collected by swab, TCT or LCT. The test utilizes Polymerase Chain Reaction (PCR) for DNA amplification and nucleic acid hybridization for the detection of low-risk HPV types in one reaction. The MeltPro HBB test kit is meant for the detection of 12 gene mutations common in the Pakistani population, which are related to β –Thalassemia and is used for β-Thalassemia screening based on polymerase chain reaction and nucleic acid hybridization. 
 

Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
Multi-Chamber Washer-Disinfector
WD 390
Chromogenic Culture System
InTray™ COLOREX™ ECC
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Illustration of the new blood test, which uses a DNA chip to detect the tumor’s biological fingerprint (Photo courtesy of Tel Aviv University)

Blood Test on a Chip Offers Low-Cost Lung Cancer Detection Without DNA Sequencing

Lung cancer is the leading cause of cancer deaths worldwide, and screening often yields indeterminate results that prompt invasive workups. Computed tomography (CT) detects small nodules but can flag benign... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Whole-Cell Genomic Analysis Expands the Potential of Liquid Biopsy

Liquid biopsy has expanded access to tumor genomics, but most blood-based assays rely on short, degraded fragments of cell-free circulating tumor DNA (ctDNA). Isolating intact circulating tumor cells from... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more

Pathology

view channel
Image: Through the PCCP, Proscia gains a more efficient pathway to expand Concentriq AP-Dx interoperability while maintaining regulatory oversight (Photo courtesy of Proscia)

FDA-Cleared Digital Pathology Platform Expands Interoperability for Primary Diagnosis

Rising cancer incidence is colliding with a shrinking pathologist workforce, intensifying pressure on diagnostic turnaround times in clinical laboratories. Many labs are adopting digital pathology to manage... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.